Russell Clayton

CIK 1530072 · Chief Medical Officer · last filed 2026-01-27

Russell Clayton is a Chief Medical Officer who has filed 8 SEC Form 4 insider transactions across 2 companies since 2011. The most recent filing, for LRMR, was dated Jan 27, 2026. Current disclosed insider exposure totals $926.0K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$926.0K

Companies

2

Total Filings

8

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
LRMR	Chief Medical Officer	71,443	$3.47	$247.9K	$0	4	2026-01-27
DSCO	Senior VP, R&D	27,320	$24.82	$678.1K	$0	4	2014-03-10

Recent Filings

8 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-01-27	LRMR	Grant (A)	+25,637	$0	EDGAR
2025-01-24	LRMR	Grant (A)	+23,306	$0	EDGAR
2024-01-19	LRMR	Grant (A)	+22,500	$0	EDGAR
2023-07-18	LRMR	Grant (A)	—	$0	EDGAR
2014-03-10	DSCO	Grant (A)	—	$0	EDGAR
2013-03-28	DSCO	Grant (A)	—	$0	EDGAR
2012-05-08	DSCO	Grant (A)	+1,586	$4.3K	EDGAR
2011-10-11	DSCO	Grant (A)	—	$0	EDGAR

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.